| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 186,004 | 163,478 | 114,349 | 167,704 | | Cost of Revenue | (17,844) | 73,418 | 67,243 | 68,646 | | | Gross Profit | 203,848 | 90,060 | 47,106 | 99,058 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 69,943 | 29,129 | 20,776 | 15,250 | | Non Recurring | (53,433) | 145,825 | (48,591) | 33,234 | | Others | 157,346 | (10,285) | 70,300 | (357,207) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,733 | (74,609) | 4,621 | 407,781 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,341 | 657 | 554 | 808 | | Earnings Before Interest And Taxes | (25,676) | (73,952) | 5,175 | 408,589 | | Interest Expense | (35,089) | 19,126 | 15,963 | 18,504 | | Income Before Tax | 9,413 | (93,078) | (10,788) | 390,085 | | Income Tax Expense | 11,189 | (31,558) | (4,885) | 123,026 | | Minority Interest |
-
| 1,653 | (1,653) | (38,054) | | | | Net Income From Continuing Ops | 7,893 | (59,867) | (7,556) | 229,005 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,893 | (59,867) | (7,556) | 229,005 | | Preferred Stock And Other Adjustments | (12,892) | 12,892 |
-
|
-
| | | Net Income Applicable To Common Shares | ($4,999) | ($46,975) | ($7,556) | $229,005 |
|
0.23% Nasdaq 
Income Statement
